Observational studyBMC cancer2022

The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study.

Chenghai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.